EP4293024
Kínasólín-efnasamband til að framkalla niðurbrot á G12D stökkbreyttu KRAS-prótíni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.2.2022EP published:
8.4.2026EP application number:
22752854.4
EP translation filed:
29.4.2026Grant published:
13.5.2026EPO information:
European Patent Register
Max expiry date:
13.2.2042Expiry date:
13.2.2027
Title in English:
QUINAZOLINE COMPOUND FOR INDUCING DEGRADATION OF G12D MUTANT KRAS PROTEINLanguage of the patent:
English
Timeline
Today
14.2.2022EP application
8.4.2026EP Publication
29.4.2026Translation submitted
13.5.2026Registration published
13.2.2027Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP
Inventor
Name:
YOSHINARI, TomohiroAddress:
Tokyo 103-8411, JP
Name:
ISHIOKA, HirokiAddress:
Tokyo 103-8411, JP
Name:
KAWAMINAMI, EijiAddress:
Tokyo 103-8411, JP
Name:
WATANABE, HideyukiAddress:
Tokyo 103-8411, JP
Name:
KAWAGUCHI, KenichiAddress:
Tokyo 103-8411, JP
Name:
KURAMOTO, KazuyukiAddress:
Tokyo 103-8411, JP
Name:
IMAIZUMI, TomoyoshiAddress:
Tokyo 103-8411, JP
Name:
MORIKAWA, TakahiroAddress:
Tokyo 103-8411, JP
Name:
HAMAGUCHI, HisaoAddress:
Tokyo 103-8411, JP
Name:
IMADA, SunaoAddress:
Tokyo 103-8411, JP
Name:
OKUMURA, MitsuakiAddress:
Tokyo 103-8411, JP
Name:
NAGASHIMA, TakeyukiAddress:
Tokyo 103-8411, JP
Name:
INAMURA, KoheiAddress:
Tokyo 103-8411, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2021021656Date:
15.2.2021Country:
JP
Classification
Categories:
C07D 487/08, A61K 31/517, A61P 35/00